Is RVPH or SCNX more undervalued in 2026?

CirclFi compares Reviva Pharmaceuticals Holdings (RVPH) and Scienture Holdings, Inc. (SCNX) using 13 institutional-grade valuation models. RVPH has a Quality of Company score of 3.7/10 while SCNX scores 4.6/10.

Which is a better buy — RVPH or SCNX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RVPH and SCNX valuations compare?

RVPH at $0.40 and SCNX at $0.41 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RVPH vs SCNX Valuation Comparison 2026 — Intrinsic Value Analysis

RVPH

Pharmaceutical Preparations

Reviva Pharmaceuticals Holdings

Quality

3.7

out of 10

Value Trap

SAFE

Price

$0.40

Last close

Models

5/13

Active

SCNX

Pharmaceutical Preparations

Scienture Holdings, Inc.

Quality

4.6

out of 10

Value Trap

WARN

Price

$0.41

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	RVPH Fair Value	RVPH Upside	SCNX Fair Value	SCNX Upside
Bayesian DCF	Intrinsic	$1.02	+153.9%	$0.12	-71.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.03	-96.6%	$1.41	+252.0%
Dynamic NAV	Asset-Based	—	—	$0.45	+9.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RVPH vs SCNX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RVPH vs SCNX — Which Stock Is More Undervalued?

SCNX scores higher with a 4.6/10 quality rating vs RVPH's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Reviva Pharmaceuticals Holdings (RVPH) and Scienture Holdings, Inc. (SCNX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RVPH currently trades at $0.40 with a QOC of 3.7/10, while SCNX trades at $0.41 with a QOC of 4.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).